ICOSAPENT ETHYL

ICOSAPENT ETHYL was reported 8757 times

ICOSAPENT ETHYL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OVERLAP SYNDROME 75 0.1071
1 PRODUCT ODOUR ABNORMAL 1055 0.1006
2 POOR QUALITY PRODUCT ADMINISTERED 669 0.0634
3 BLOOD IMMUNOGLOBULIN M INCREASED 32 0.0526
4 C-REACTIVE PROTEIN 46 0.0496
5 BLOOD IMMUNOGLOBULIN A DECREASED 32 0.0492
6 PRODUCT COATING ISSUE 49 0.0480
7 ANTACID THERAPY 6 0.0462
8 PRODUCT PHYSICAL ISSUE 916 0.0454
9 MILK-ALKALI SYNDROME 23 0.0440
10 PRODUCT COLOUR ISSUE 225 0.0438
11 PEPTOSTREPTOCOCCUS INFECTION 4 0.0381
12 PRODUCT AFTER TASTE 33 0.0346
13 MALIGNANT MELANOMA STAGE 0 7 0.0335
14 PRODUCT TASTE ABNORMAL 451 0.0333
15 BLOOD TRIGLYCERIDES ABNORMAL 29 0.0331
16 HYPOCHOLESTEROLAEMIA 11 0.0312
17 CONGENITAL HIATUS HERNIA 7 0.0307
18 SLEEP DISORDER THERAPY 6 0.0303
19 BLOOD IMMUNOGLOBULIN G INCREASED 32 0.0263
20 RHEUMATIC DISORDER 42 0.0217
21 INTENTIONAL UNDERDOSE 158 0.0216
22 ANTICOAGULANT THERAPY 6 0.0211
23 FACET JOINT SYNDROME 64 0.0196
24 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 13 0.0195
25 LUPUS VULGARIS 24 0.0190
26 ANALGESIC THERAPY 6 0.0187
27 PRODUCT SIZE ISSUE 97 0.0180
28 PRODUCT LEAKAGE 100 0.0178
29 DRUG THERAPY 6 0.0177
30 BLOOD TRIGLYCERIDES INCREASED 312 0.0176
31 RETINITIS 30 0.0174
32 PORPHYRIA ACUTE 23 0.0160
33 HYDROURETER 6 0.0158
34 PRESCRIBED UNDERDOSE 314 0.0157
35 SERONEGATIVE ARTHRITIS 17 0.0148
36 ERUCTATION 281 0.0145
37 DEEP VEIN THROMBOSIS POSTOPERATIVE 26 0.0130
38 BLOOD TRIGLYCERIDES DECREASED 4 0.0119
39 X-RAY ABNORMAL 20 0.0112
40 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 6 0.0107
41 MUSCLE INJURY 86 0.0104
42 HEPATIC NECROSIS 39 0.0103
43 DRUG TOLERANCE DECREASED 29 0.0103
44 HELICOBACTER INFECTION 98 0.0095
45 COLITIS MICROSCOPIC 44 0.0093
46 DUODENAL ULCER PERFORATION 69 0.0093
47 DISLOCATION OF VERTEBRA 21 0.0092
48 C-REACTIVE PROTEIN ABNORMAL 59 0.0092
49 BREAST CANCER STAGE III 59 0.0091
50 SWOLLEN JOINT COUNT INCREASED 29 0.0091
51 PRODUCT RESIDUE PRESENT 49 0.0091
52 RHEUMATIC FEVER 39 0.0087
53 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 18 0.0087
54 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 55 0.0085
55 LIP DRY 72 0.0079
56 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 7 0.0076
57 CATARACT OPERATION 44 0.0074
58 CARDIOVERSION 10 0.0072
59 PERIPHERAL VENOUS DISEASE 29 0.0071
60 LIVE BIRTH 59 0.0070
61 HEPATIC ENZYME ABNORMAL 35 0.0070
62 PEMPHIGUS 87 0.0070
63 PRODUCT CONTAINER SEAL ISSUE 12 0.0069
64 HYPOCHLORAEMIA 8 0.0068
65 GASTROINTESTINAL POLYP HAEMORRHAGE 4 0.0066
66 LOW DENSITY LIPOPROTEIN ABNORMAL 4 0.0065
67 SCIATICA 104 0.0065
68 CALCULUS URINARY 10 0.0065
69 WOUND INFECTION 70 0.0064
70 NAIL DISORDER 55 0.0063
71 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 45 0.0063
72 PANCREATITIS RELAPSING 5 0.0061
73 HAND DEFORMITY 79 0.0060
74 BRONCHITIS VIRAL 4 0.0059
75 SUSPECTED PRODUCT CONTAMINATION 6 0.0059
76 MULTIPLE ALLERGIES 45 0.0057
77 BONE DEMINERALISATION 6 0.0057
78 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 6 0.0056
79 BONE EROSION 19 0.0054
80 RHEUMATOID FACTOR POSITIVE 31 0.0054
81 BREATH ODOUR 13 0.0053
82 JOINT DESTRUCTION 8 0.0051
83 EYELID RASH 5 0.0051
84 HIGH DENSITY LIPOPROTEIN DECREASED 17 0.0051
85 FOREIGN BODY IN THROAT 16 0.0051
86 CARDIAC ABLATION 9 0.0050
87 BURSITIS 61 0.0050
88 PERICARDITIS 84 0.0050
89 LOW DENSITY LIPOPROTEIN DECREASED 7 0.0049
90 RED BLOOD CELL SEDIMENTATION RATE INCREASED 54 0.0049
91 HEPATIC ENCEPHALOPATHY 45 0.0048
92 HYPERPARATHYROIDISM SECONDARY 12 0.0048
93 PERIORBITAL PAIN 4 0.0047
94 SYNOVITIS 85 0.0047
95 HYPERPHOSPHATAEMIA 10 0.0046
96 FIBROMYALGIA 112 0.0046
97 FOREIGN BODY IN RESPIRATORY TRACT 6 0.0046
98 HISTOPLASMOSIS 8 0.0045
99 HYPERTRIGLYCERIDAEMIA 26 0.0044
100 ULCER HAEMORRHAGE 30 0.0044
101 TYPE 2 DIABETES MELLITUS 145 0.0043
102 OBESITY 68 0.0043
103 GOUT 75 0.0042
104 RETCHING 89 0.0042
105 PROSTATIC OPERATION 5 0.0041
106 SPONDYLITIS 15 0.0041
107 PRODUCT ADHESION ISSUE 146 0.0041
108 INFUSION SITE REACTION 12 0.0040
109 FOLLICULITIS 42 0.0040
110 PANCREATITIS NECROTISING 9 0.0039
111 NEPHROGENIC ANAEMIA 18 0.0039
112 SKIN ODOUR ABNORMAL 15 0.0038
113 PSORIATIC ARTHROPATHY 154 0.0038
114 REGURGITATION 13 0.0038
115 EYE INJURY 11 0.0036
116 DRUG-INDUCED LIVER INJURY 112 0.0036
117 HEPATIC CIRRHOSIS 66 0.0035
118 PRODUCT DISPENSING ISSUE 15 0.0035
119 LOW DENSITY LIPOPROTEIN INCREASED 27 0.0035
120 PRESCRIBED OVERDOSE 67 0.0035
121 HYPERCHOLESTEROLAEMIA 33 0.0034
122 BLEPHAROSPASM 21 0.0033
123 PRODUCT CONTAINER ISSUE 28 0.0033
124 PLEURITIC PAIN 9 0.0033
125 LIVER INJURY 80 0.0033
126 PRODUCT USE COMPLAINT 51 0.0032
127 THERAPY INTERRUPTED 226 0.0032
128 SKIN REACTION 44 0.0031
129 LOWER LIMB FRACTURE 60 0.0031
130 IMMUNE-MEDIATED MYOCARDITIS 5 0.0031
131 JOINT RANGE OF MOTION DECREASED 41 0.0031
132 CONTRAINDICATED PRODUCT ADMINISTERED 92 0.0030
133 HYPOPHOSPHATAEMIA 22 0.0030
134 AUTOIMMUNE DISORDER 29 0.0030
135 MATERNAL EXPOSURE TIMING UNSPECIFIED 11 0.0029
136 PANNICULITIS 7 0.0029
137 IMMUNODEFICIENCY 43 0.0029
138 ONYCHOMADESIS 12 0.0029
139 RESPIRATORY SYMPTOM 8 0.0028
140 C-REACTIVE PROTEIN INCREASED 100 0.0027
141 ESSENTIAL HYPERTENSION 5 0.0027
142 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 9 0.0027
143 OSTEOARTHRITIS 114 0.0027
144 HERNIA 51 0.0026
145 CARDIAC FLUTTER 17 0.0026
146 MUSCULOSKELETAL PAIN 135 0.0026
147 NEOPLASM SKIN 4 0.0026
148 PULMONARY FIBROSIS 49 0.0026
149 URINE ODOUR ABNORMAL 15 0.0025
150 MEDICATION RESIDUE PRESENT 12 0.0025
151 BLOOD CHOLESTEROL INCREASED 117 0.0025
152 MULTIPLE FRACTURES 41 0.0025
153 IMPAIRED GASTRIC EMPTYING 34 0.0025
154 MOBILITY DECREASED 179 0.0025
155 SPINAL FUSION SURGERY 10 0.0025
156 JOINT DISLOCATION 26 0.0025
157 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 42 0.0024
158 CARTILAGE INJURY 6 0.0024
159 HAEMOGLOBIN INCREASED 11 0.0024
160 PRODUCT LABEL ISSUE 16 0.0024
161 SYSTEMIC LUPUS ERYTHEMATOSUS 83 0.0023
162 GLAUCOMA 45 0.0023
163 BENIGN PROSTATIC HYPERPLASIA 12 0.0023
164 DIVERTICULITIS 64 0.0023
165 EXOSTOSIS 21 0.0023
166 COLONOSCOPY 5 0.0023
167 MULTIPLE-DRUG RESISTANCE 7 0.0023
168 STENT PLACEMENT 18 0.0022
169 LUPUS-LIKE SYNDROME 20 0.0022
170 ARTHROPATHY 122 0.0022
171 ROAD TRAFFIC ACCIDENT 91 0.0022
172 CORONARY ARTERIAL STENT INSERTION 11 0.0022
173 IRRITABLE BOWEL SYNDROME 46 0.0021
174 STOMATITIS 130 0.0021
175 HEPATOTOXICITY 47 0.0021
176 WEIGHT FLUCTUATION 22 0.0021
177 CORONARY ARTERY BYPASS 12 0.0021
178 BLOOD URIC ACID INCREASED 12 0.0021
179 IMMUNE-MEDIATED HEPATIC DISORDER 4 0.0020
180 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
181 JOINT NOISE 4 0.0020
182 THERAPEUTIC PRODUCT EFFECT DECREASED 91 0.0020
183 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
184 END STAGE RENAL DISEASE 37 0.0020
185 HYPERTRANSAMINASAEMIA 14 0.0020
186 AORTIC STENOSIS 7 0.0020
187 GAMMA-GLUTAMYLTRANSFERASE INCREASED 44 0.0020
188 WALKING AID USER 13 0.0020
189 PRODUCT CONTAMINATION 7 0.0020
190 LOWER RESPIRATORY TRACT INFECTION 89 0.0020
191 CHANGE OF BOWEL HABIT 4 0.0019
192 BLOOD CHOLESTEROL ABNORMAL 9 0.0019
193 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 12 0.0019
194 PHYSICAL DECONDITIONING 5 0.0019
195 UNDERDOSE 141 0.0019
196 EPILEPSY 58 0.0019
197 NON-CARDIAC CHEST PAIN 6 0.0019
198 HIP ARTHROPLASTY 29 0.0019
199 PRODUCT DISPENSING ERROR 41 0.0019
200 CARDIAC FAILURE CHRONIC 8 0.0019
201 GLOSSODYNIA 41 0.0018
202 TASTE DISORDER 37 0.0018
203 THERAPEUTIC RESPONSE UNEXPECTED 81 0.0018
204 GASTRIC ULCER HAEMORRHAGE 10 0.0018
205 FOOT DEFORMITY 20 0.0018
206 MATERNAL EXPOSURE DURING PREGNANCY 160 0.0018
207 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 9 0.0018
208 GASTROINTESTINAL HYPOMOTILITY 4 0.0018
209 DYSLIPIDAEMIA 9 0.0018
210 DISTRIBUTIVE SHOCK 4 0.0018
211 MYASTHENIA GRAVIS 14 0.0017
212 GLOMERULAR FILTRATION RATE DECREASED 21 0.0017
213 TROPONIN INCREASED 13 0.0017
214 GRIP STRENGTH DECREASED 15 0.0017
215 DYSGEUSIA 126 0.0017
216 RADIUS FRACTURE 4 0.0017
217 PAINFUL RESPIRATION 4 0.0017
218 ABDOMINAL DISCOMFORT 278 0.0017
219 LIVER FUNCTION TEST INCREASED 35 0.0016
220 CARDIAC OPERATION 14 0.0016
221 PORTAL HYPERTENSION 5 0.0016
222 IMPAIRED HEALING 53 0.0016
223 BLOOD ALKALINE PHOSPHATASE INCREASED 40 0.0016
224 SINUSITIS 164 0.0016
225 HEPATIC ENZYME INCREASED 109 0.0016
226 CATHETERISATION CARDIAC 7 0.0016
227 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
228 WOUND 44 0.0016
229 PARANASAL SINUS HYPERSECRETION 6 0.0016
230 HAEMORRHAGE URINARY TRACT 4 0.0016
231 DYSPEPSIA 154 0.0016
232 BACK INJURY 17 0.0016
233 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 75 0.0016
234 PRODUCT TEMPERATURE EXCURSION ISSUE 8 0.0016
235 FOOD ALLERGY 12 0.0016
236 BLOOD CHLORIDE DECREASED 4 0.0015
237 CYSTITIS 49 0.0015
238 EYE DISORDER 50 0.0015
239 DRUG RESISTANCE 39 0.0015
240 POLYDIPSIA 6 0.0015
241 LUNG OPACITY 4 0.0015
242 POLYARTHRITIS 8 0.0015
243 SWELLING 142 0.0015
244 FAECES SOFT 11 0.0015
245 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
246 OEDEMA 81 0.0015
247 KNEE ARTHROPLASTY 31 0.0015
248 CORONARY ARTERY OCCLUSION 20 0.0015
249 PUSTULAR PSORIASIS 5 0.0015
250 SPINAL STENOSIS 6 0.0015
251 IMMUNE-MEDIATED MYOSITIS 4 0.0014
252 CHOKING SENSATION 8 0.0014
253 WHEEZING 86 0.0014
254 GRANULOMA 5 0.0014
255 THROAT CANCER 6 0.0014
256 ATRIAL FIBRILLATION 137 0.0014
257 FREQUENT BOWEL MOVEMENTS 38 0.0014
258 GAIT INABILITY 47 0.0014
259 SHOULDER OPERATION 6 0.0014
260 EAR INFECTION 37 0.0014
261 INFLAMMATION 71 0.0014
262 ABNORMAL FAECES 11 0.0013
263 HEPATIC STEATOSIS 25 0.0013
264 GASTROOESOPHAGEAL REFLUX DISEASE 108 0.0013
265 HYPERLIPIDAEMIA 16 0.0013
266 CHOKING 26 0.0013
267 CHRONIC KIDNEY DISEASE 101 0.0013
268 BRONCHITIS 98 0.0013
269 IRITIS 4 0.0013
270 PERIPHERAL SWELLING 202 0.0013
271 INSURANCE ISSUE 20 0.0013
272 GLYCOSYLATED HAEMOGLOBIN INCREASED 33 0.0013
273 DRUG INTOLERANCE 126 0.0013
274 OESOPHAGEAL DISORDER 5 0.0013
275 INTENTIONAL DOSE OMISSION 37 0.0013
276 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
277 THERAPY NON-RESPONDER 58 0.0013
278 IMMUNE SYSTEM DISORDER 17 0.0013
279 PANCREATITIS 68 0.0013
280 ASPIRATION 14 0.0013
281 BLOOD MAGNESIUM DECREASED 11 0.0013
282 NIGHT SWEATS 41 0.0013
283 FLATULENCE 72 0.0013
284 INFUSION SITE PRURITUS 4 0.0013
285 OSTEOPOROSIS 52 0.0013
286 HYPOAESTHESIA 189 0.0013
287 RHEUMATOID ARTHRITIS 142 0.0012
288 MYELOSUPPRESSION 45 0.0012
289 CUSHINGOID 4 0.0012
290 DIZZINESS POSTURAL 12 0.0012
291 ANGINA UNSTABLE 8 0.0012
292 POLYP 8 0.0012
293 HYPOMAGNESAEMIA 17 0.0012
294 BREATH SOUNDS ABNORMAL 6 0.0012
295 FOOT OPERATION 6 0.0012
296 JOINT SWELLING 146 0.0012
297 ARTHRALGIA 501 0.0012
298 HYDRONEPHROSIS 9 0.0012
299 PRODUCT LABEL CONFUSION 7 0.0012
300 CORONARY ARTERY STENOSIS 6 0.0012
301 PAROSMIA 9 0.0012
302 CATARACT 71 0.0012
303 PRODUCT SOLUBILITY ABNORMAL 6 0.0012
304 INFUSION RELATED REACTION 78 0.0012
305 ALANINE AMINOTRANSFERASE INCREASED 72 0.0012
306 BACK DISORDER 19 0.0012
307 HEPATIC FIBROSIS 4 0.0012
308 PRODUCT PACKAGING ISSUE 11 0.0012
309 FOETAL DEATH 6 0.0012
310 ADRENAL INSUFFICIENCY 14 0.0012
311 POLYMENORRHOEA 4 0.0012
312 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
313 DIVERTICULUM INTESTINAL 5 0.0011
314 ANHEDONIA 30 0.0011
315 BLOOD GLUCOSE INCREASED 215 0.0011
316 FULL BLOOD COUNT ABNORMAL 12 0.0011
317 PRODUCT STORAGE ERROR 99 0.0011
318 NASOPHARYNGITIS 207 0.0011
319 TREATMENT FAILURE 93 0.0011
320 INFUSION SITE SWELLING 7 0.0011
321 ANAL INCONTINENCE 10 0.0011
322 NORMAL NEWBORN 6 0.0011
323 INCREASED APPETITE 21 0.0011
324 BLOOD GLUCOSE FLUCTUATION 12 0.0011
325 EYE OPERATION 5 0.0011
326 LIVER DISORDER 48 0.0011
327 BREAST CANCER STAGE II 9 0.0011
328 RENAL FUNCTION TEST ABNORMAL 5 0.0011
329 BONE DENSITY ABNORMAL 4 0.0011
330 URTICARIA 179 0.0011
331 NEPHROLITHIASIS 49 0.0011
332 ANAPHYLACTIC REACTION 59 0.0011
333 SEASONAL ALLERGY 15 0.0011
334 BLOOD PRESSURE INCREASED 162 0.0011
335 MYALGIA 180 0.0011
336 CORONAVIRUS INFECTION 7 0.0011
337 CORONARY ARTERY DISEASE 32 0.0011
338 APPETITE DISORDER 7 0.0011
339 FACE INJURY 4 0.0011
340 CONTUSION 101 0.0010
341 RECALLED PRODUCT ADMINISTERED 10 0.0010
342 BLOOD POTASSIUM INCREASED 17 0.0010
343 LUNG DISORDER 51 0.0010
344 RASH VESICULAR 5 0.0010
345 COELIAC DISEASE 10 0.0010
346 ARTERIAL OCCLUSIVE DISEASE 8 0.0010
347 ARTHRITIS 80 0.0010
348 DISCOMFORT 62 0.0010
349 WEIGHT INCREASED 227 0.0010
350 HYPERVOLAEMIA 5 0.0010
351 TRICUSPID VALVE INCOMPETENCE 8 0.0010
352 INTENTIONAL PRODUCT USE ISSUE 88 0.0010
353 HYPERPHAGIA 4 0.0010
354 ATRIAL FLUTTER 8 0.0010
355 BLOOD TEST ABNORMAL 14 0.0010
356 ABDOMINAL PAIN UPPER 205 0.0010
357 GALLBLADDER OPERATION 4 0.0010
358 MUSCLE TIGHTNESS 16 0.0010
359 SARS-COV-2 TEST POSITIVE 13 0.0010
360 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
361 SLEEP DISORDER 69 0.0010
362 IRON DEFICIENCY ANAEMIA 9 0.0010
363 HYPERURICAEMIA 4 0.0010
364 PRODUCT DISTRIBUTION ISSUE 9 0.0010
365 PRE-EXISTING CONDITION IMPROVED 6 0.0010
366 MYOCARDITIS 11 0.0010
367 DIABETES MELLITUS 73 0.0010
368 DIARRHOEA 614 0.0010
369 ARTHROPOD BITE 7 0.0009
370 CONDITION AGGRAVATED 286 0.0009
371 HERPES ZOSTER 54 0.0009
372 FEEDING DISORDER 19 0.0009
373 FOOD POISONING 5 0.0009
374 ATELECTASIS 9 0.0009
375 NEUROLEPTIC MALIGNANT SYNDROME 11 0.0009
376 HIP SURGERY 5 0.0009
377 OSTEOPENIA 14 0.0009
378 PRODUCT AVAILABILITY ISSUE 21 0.0009
379 TENDON DISORDER 6 0.0009
380 BLOOD CALCIUM INCREASED 8 0.0009
381 TOOTH INFECTION 12 0.0009
382 OFF LABEL USE 796 0.0009
383 GASTROINTESTINAL PAIN 10 0.0009
384 PAIN IN EXTREMITY 267 0.0009
385 GINGIVAL SWELLING 4 0.0009
386 BLOOD PRESSURE ABNORMAL 18 0.0009
387 RENAL IMPAIRMENT 76 0.0009
388 BLOOD CREATINE INCREASED 4 0.0009
389 PREGNANCY 18 0.0009
390 THIRST 16 0.0009
391 MUSCULOSKELETAL STIFFNESS 78 0.0009
392 DRY MOUTH 72 0.0009
393 OROPHARYNGEAL DISCOMFORT 8 0.0009
394 ACUTE RESPIRATORY FAILURE 17 0.0009
395 PRODUCT DOSE OMISSION IN ERROR 25 0.0009
396 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
397 HYPERTENSION 186 0.0009
398 BLOOD TESTOSTERONE DECREASED 6 0.0009
399 MICTURITION URGENCY 10 0.0009
400 IMMUNE THROMBOCYTOPENIA 4 0.0009
401 MUSCLE SPASMS 159 0.0009
402 LARGE INTESTINE POLYP 6 0.0009
403 EXTRASYSTOLES 6 0.0009
404 MASS 12 0.0009
405 SINUS DISORDER 17 0.0009
406 THERAPY CESSATION 44 0.0009
407 BLISTER 48 0.0009
408 FLANK PAIN 8 0.0009
409 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
410 RASH PRURITIC 46 0.0008
411 GASTRIC ULCER 16 0.0008
412 CARDIAC PACEMAKER INSERTION 5 0.0008
413 NON-SMALL CELL LUNG CANCER 4 0.0008
414 ACCIDENTAL UNDERDOSE 12 0.0008
415 BRAIN FOG 13 0.0008
416 PULMONARY ARTERIAL HYPERTENSION 12 0.0008
417 NOCTURIA 10 0.0008
418 NECK PAIN 46 0.0008
419 UPPER RESPIRATORY TRACT INFECTION 38 0.0008
420 CONSTIPATION 179 0.0008
421 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
422 VITAMIN D DECREASED 7 0.0008
423 ULCER 13 0.0008
424 PRODUCT DOSE OMISSION ISSUE 240 0.0008
425 SINUS CONGESTION 11 0.0008
426 ADVERSE EVENT 75 0.0008
427 SPINAL OPERATION 10 0.0008
428 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
429 PROTEIN URINE PRESENT 4 0.0008
430 DYSPHAGIA 76 0.0008
431 JOINT STIFFNESS 21 0.0008
432 GENERAL SYMPTOM 6 0.0008
433 MITRAL VALVE INCOMPETENCE 9 0.0008
434 GASTROINTESTINAL DISORDER 71 0.0008
435 BLOOD GLUCOSE DECREASED 38 0.0008
436 FOOT FRACTURE 15 0.0008
437 ALOPECIA 155 0.0008
438 CHOLECYSTECTOMY 9 0.0008
439 MIGRAINE 75 0.0008
440 HYPOTHYROIDISM 25 0.0008
441 PLATELET COUNT DECREASED 83 0.0008
442 PERIPHERAL VASCULAR DISORDER 4 0.0008
443 INFUSION SITE PAIN 10 0.0008
444 CONGENITAL ANOMALY 6 0.0008
445 EAR PAIN 15 0.0008
446 ADVERSE DRUG REACTION 69 0.0008
447 INJURY 54 0.0008
448 MALABSORPTION 4 0.0008
449 COVID-19 PNEUMONIA 9 0.0008
450 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
451 INCONTINENCE 8 0.0008
452 ABDOMINAL DISTENSION 78 0.0007
453 INSOMNIA 197 0.0007
454 WHITE BLOOD CELL COUNT DECREASED 80 0.0007
455 HYPOKALAEMIA 34 0.0007
456 PROSTATIC SPECIFIC ANTIGEN INCREASED 10 0.0007
457 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 147 0.0007
458 COVID-19 127 0.0007
459 DECREASED APPETITE 168 0.0007
460 PRODUCT PHYSICAL CONSISTENCY ISSUE 4 0.0007
461 HEART RATE ABNORMAL 4 0.0007
462 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
463 OROPHARYNGEAL PAIN 66 0.0007
464 HEPATOMEGALY 7 0.0007
465 PANCREATITIS ACUTE 16 0.0007
466 GENERAL PHYSICAL HEALTH DETERIORATION 82 0.0007
467 BLOOD PRESSURE DECREASED 47 0.0007
468 PULMONARY TOXICITY 5 0.0007
469 CHOLECYSTITIS ACUTE 4 0.0007
470 ROTATOR CUFF SYNDROME 9 0.0007
471 PRODUCT SUPPLY ISSUE 5 0.0007
472 INTERNAL HAEMORRHAGE 8 0.0007
473 BLOOD POTASSIUM DECREASED 21 0.0007
474 NAUSEA 552 0.0007
475 MUSCULOSKELETAL DISCOMFORT 12 0.0007
476 HEPATIC FUNCTION ABNORMAL 26 0.0007
477 POLLAKIURIA 29 0.0007
478 EXERCISE TOLERANCE DECREASED 4 0.0007
479 MUSCLE STRAIN 6 0.0007
480 PRODUCT ADMINISTRATION ERROR 14 0.0007
481 PYELONEPHRITIS 6 0.0007
482 DELIRIUM 24 0.0007
483 EYE PAIN 39 0.0007
484 URINE OUTPUT DECREASED 6 0.0007
485 SPINAL PAIN 8 0.0007
486 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 123 0.0007
487 PRODUCT COMMUNICATION ISSUE 6 0.0007
488 ACUTE KIDNEY INJURY 104 0.0007
489 SENSITIVE SKIN 5 0.0007
490 ASPARTATE AMINOTRANSFERASE INCREASED 36 0.0007
491 HOT FLUSH 51 0.0007
492 VENTRICULAR EXTRASYSTOLES 7 0.0007
493 CHOLECYSTITIS 8 0.0007
494 PULMONARY MASS 10 0.0007
495 PAIN IN JAW 19 0.0007
496 ODYNOPHAGIA 4 0.0007
497 MYOSITIS 6 0.0007
498 INJECTION SITE DISCOMFORT 7 0.0007
499 BREAST TENDERNESS 5 0.0007
500 HEART RATE IRREGULAR 15 0.0007
501 DRUG INTERACTION 105 0.0007
502 TENDON PAIN 5 0.0007
503 RENAL PAIN 7 0.0007
504 PRODUCT USE ISSUE 124 0.0007
505 TREATMENT NONCOMPLIANCE 36 0.0007
506 PALPITATIONS 77 0.0007
507 DISABILITY 13 0.0007
508 CONFUSIONAL STATE 106 0.0007
509 JOINT INJURY 14 0.0007
510 MEMORY IMPAIRMENT 90 0.0007
511 CEREBRAL INFARCTION 16 0.0007
512 PNEUMONIA BACTERIAL 6 0.0007
513 MYOCARDIAL INFARCTION 114 0.0007
514 MENISCUS INJURY 4 0.0006
515 CARDIOMEGALY 8 0.0006
516 DECREASED ACTIVITY 7 0.0006
517 PIGMENTATION DISORDER 4 0.0006
518 HEART RATE INCREASED 64 0.0006
519 FAECES DISCOLOURED 14 0.0006
520 PRODUCT DOSE OMISSION 42 0.0006
521 BACTERIAL INFECTION 12 0.0006
522 PELVIC FRACTURE 5 0.0006
523 ARTERIOSCLEROSIS 6 0.0006
524 RENAL CYST 5 0.0006
525 SLEEP APNOEA SYNDROME 12 0.0006
526 RECTAL HAEMORRHAGE 27 0.0006
527 ASTHMA 71 0.0006
528 BLOOD CREATININE INCREASED 41 0.0006
529 OEDEMA PERIPHERAL 76 0.0006
530 CHEST PAIN 115 0.0006
531 BACK PAIN 144 0.0006
532 NEURALGIA 15 0.0006
533 PHARYNGEAL SWELLING 6 0.0006
534 DIZZINESS 305 0.0006
535 ACUTE MYOCARDIAL INFARCTION 18 0.0006
536 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
537 HAIR DISORDER 5 0.0006
538 BLADDER DISORDER 6 0.0006
539 COLON CANCER 9 0.0006
540 POOR QUALITY SLEEP 13 0.0006
541 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
542 RESPIRATORY DISORDER 18 0.0006
543 EOSINOPHIL COUNT INCREASED 5 0.0006
544 INTERSTITIAL LUNG DISEASE 29 0.0006
545 HYPERKALAEMIA 21 0.0006
546 MUSCULAR WEAKNESS 68 0.0006
547 SPLENOMEGALY 7 0.0006
548 MALIGNANT MELANOMA 8 0.0006
549 BLOOD GLUCOSE ABNORMAL 11 0.0006
550 ECONOMIC PROBLEM 9 0.0006
551 THERAPEUTIC RESPONSE DECREASED 36 0.0006
552 FATIGUE 462 0.0006
553 INFUSION SITE ERYTHEMA 5 0.0006
554 ILLNESS 61 0.0006
555 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
556 BLOOD IRON DECREASED 7 0.0006
557 BACTERAEMIA 7 0.0006
558 PRODUCT PRESCRIBING ERROR 14 0.0006
559 PHOTOPHOBIA 11 0.0006
560 INITIAL INSOMNIA 6 0.0006
561 DEVICE RELATED INFECTION 9 0.0006
562 THYROID DISORDER 9 0.0006
563 DIABETIC KETOACIDOSIS 14 0.0006
564 VOMITING 273 0.0006
565 WEIGHT DECREASED 162 0.0006
566 LABORATORY TEST ABNORMAL 17 0.0006
567 CHROMATURIA 13 0.0006
568 INFECTION 83 0.0006
569 RHINORRHOEA 37 0.0006
570 RENAL INJURY 17 0.0006
571 ASTHENIA 215 0.0006
572 DUODENAL ULCER 4 0.0006
573 TENDON RUPTURE 7 0.0006
574 RASH 246 0.0006
575 ILEUS 7 0.0006
576 EXPOSURE DURING PREGNANCY 35 0.0006
577 BREAST PAIN 6 0.0006
578 PERICARDIAL EFFUSION 13 0.0006
579 EPISTAXIS 42 0.0006
580 PNEUMONIA ASPIRATION 14 0.0006
581 INJECTION SITE DISCOLOURATION 7 0.0006
582 PARAESTHESIA ORAL 8 0.0006
583 PHARYNGITIS STREPTOCOCCAL 6 0.0006
584 PRURITUS 213 0.0006
585 LIMB INJURY 15 0.0006
586 RESTLESS LEGS SYNDROME 10 0.0005
587 RENAL FAILURE 73 0.0005
588 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
589 DYSSTASIA 16 0.0005
590 DYSPHONIA 32 0.0005
591 HOSPITALISATION 84 0.0005
592 CEREBROVASCULAR ACCIDENT 92 0.0005
593 NERVE COMPRESSION 5 0.0005
594 EXPIRED PRODUCT ADMINISTERED 18 0.0005
595 CONJUNCTIVITIS 10 0.0005
596 LOCALISED INFECTION 13 0.0005
597 BLOOD UREA INCREASED 9 0.0005
598 MALNUTRITION 6 0.0005
599 NEPHROPATHY 5 0.0005
600 MIDDLE INSOMNIA 10 0.0005
601 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
602 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
603 ORAL CANDIDIASIS 7 0.0005
604 LACRIMATION INCREASED 16 0.0005
605 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
606 GAIT DISTURBANCE 101 0.0005
607 URINARY TRACT INFECTION 90 0.0005
608 BLOOD URINE PRESENT 10 0.0005
609 ILL-DEFINED DISORDER 32 0.0005
610 PROTEINURIA 10 0.0005
611 AORTIC ANEURYSM 4 0.0005
612 INTENTIONAL PRODUCT MISUSE 46 0.0005
613 ANGINA PECTORIS 15 0.0005
614 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
615 EYE IRRITATION 30 0.0005
616 SEROTONIN SYNDROME 10 0.0005
617 HYPERSENSITIVITY 96 0.0005
618 LIMB DISCOMFORT 16 0.0005
619 VITAMIN D DEFICIENCY 5 0.0005
620 SURGERY 30 0.0005
621 PERIPHERAL COLDNESS 7 0.0005
622 VISUAL IMPAIRMENT 63 0.0005
623 KNEE OPERATION 5 0.0005
624 HOSPICE CARE 5 0.0005
625 GALLBLADDER DISORDER 9 0.0005
626 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
627 ACCIDENT 6 0.0005
628 GASTROENTERITIS VIRAL 9 0.0005
629 HAEMATURIA 17 0.0005
630 HEADACHE 311 0.0005
631 FRUSTRATION TOLERANCE DECREASED 4 0.0005
632 MUSCLE DISORDER 4 0.0005
633 PRESYNCOPE 12 0.0005
634 NASAL CONGESTION 29 0.0005
635 PLEURAL EFFUSION 30 0.0005
636 DRY THROAT 5 0.0005
637 POST PROCEDURAL INFECTION 4 0.0005
638 SNEEZING 11 0.0005
639 EAR DISCOMFORT 5 0.0005
640 RIB FRACTURE 10 0.0005
641 OCULAR HYPERAEMIA 23 0.0005
642 HYPERTHYROIDISM 7 0.0005
643 CYST 6 0.0005
644 AGEUSIA 12 0.0005
645 LIP SWELLING 16 0.0005
646 PETECHIAE 5 0.0005
647 BONE DENSITY DECREASED 15 0.0005
648 ATRIAL SEPTAL DEFECT 4 0.0005
649 PNEUMONIA 154 0.0005
650 BALANCE DISORDER 41 0.0005
651 SCRATCH 5 0.0005
652 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 16 0.0005
653 CARDIAC FAILURE 38 0.0005
654 ABDOMINAL PAIN 110 0.0005
655 CARDIOVASCULAR DISORDER 12 0.0005
656 SKIN HAEMORRHAGE 7 0.0005
657 FEELING JITTERY 9 0.0005
658 RENAL DISORDER 22 0.0005
659 FLUID RETENTION 24 0.0005
660 HYPOPHAGIA 12 0.0005
661 POST PROCEDURAL COMPLICATION 9 0.0005
662 THROAT IRRITATION 21 0.0005
663 BONE LOSS 7 0.0005
664 PYREXIA 161 0.0005
665 INJECTION SITE INDURATION 6 0.0005
666 SKIN LACERATION 5 0.0005
667 NODULE 6 0.0005
668 SEPTIC SHOCK 20 0.0005
669 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
670 FEELING HOT 28 0.0005
671 PHARYNGEAL OEDEMA 7 0.0005
672 MUSCULOSKELETAL CHEST PAIN 7 0.0005
673 DENTAL CARIES 5 0.0005
674 VIRAL INFECTION 15 0.0005
675 FEELING ABNORMAL 108 0.0005
676 DYSPNOEA 255 0.0005
677 EYE HAEMORRHAGE 6 0.0004
678 CHEST DISCOMFORT 46 0.0004
679 BASAL CELL CARCINOMA 7 0.0004
680 CYTOKINE RELEASE SYNDROME 9 0.0004
681 DRUG INEFFECTIVE 585 0.0004
682 PRODUCT USE IN UNAPPROVED INDICATION 110 0.0004
683 EYE INFECTION 5 0.0004
684 LEUKOCYTOSIS 8 0.0004
685 NEUROPATHY PERIPHERAL 42 0.0004
686 BODY TEMPERATURE INCREASED 9 0.0004
687 DRY EYE 22 0.0004
688 GINGIVAL BLEEDING 6 0.0004
689 PAIN 269 0.0004
690 METABOLIC ACIDOSIS 14 0.0004
691 ACCIDENTAL OVERDOSE 16 0.0004
692 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
693 INCREASED TENDENCY TO BRUISE 4 0.0004
694 GASTRIC HAEMORRHAGE 5 0.0004
695 HAEMATEMESIS 11 0.0004
696 INJECTION SITE MASS 16 0.0004
697 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
698 ORAL DISCOMFORT 6 0.0004
699 EYE SWELLING 16 0.0004
700 DERMATITIS 9 0.0004
701 DEVICE OCCLUSION 6 0.0004
702 PARAESTHESIA 67 0.0004
703 CARDIAC FAILURE CONGESTIVE 34 0.0004
704 INFLUENZA 47 0.0004
705 COUGH 118 0.0004
706 MUSCULOSKELETAL DISORDER 8 0.0004
707 RED BLOOD CELL COUNT DECREASED 12 0.0004
708 URINARY RETENTION 14 0.0004
709 WHITE BLOOD CELL COUNT INCREASED 16 0.0004
710 PRURITUS GENERALISED 9 0.0004
711 ANOSMIA 6 0.0004
712 INJECTION SITE BRUISING 33 0.0004
713 SEPSIS 46 0.0004
714 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
715 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
716 SMALL INTESTINAL OBSTRUCTION 5 0.0004
717 HYPERCALCAEMIA 5 0.0004
718 LIGAMENT SPRAIN 4 0.0004
719 INABILITY TO AFFORD MEDICATION 4 0.0004
720 COLITIS ULCERATIVE 18 0.0004
721 UPPER LIMB FRACTURE 8 0.0004
722 BRAIN INJURY 4 0.0004
723 HAEMATOCHEZIA 22 0.0004
724 ANXIETY 113 0.0004
725 CELLULITIS 20 0.0004
726 MALAISE 174 0.0004
727 FALL 132 0.0004
728 EMPHYSEMA 4 0.0004
729 PRODUCT QUALITY ISSUE 53 0.0004
730 DEHYDRATION 52 0.0004
731 PRODUCT PREPARATION ERROR 8 0.0004
732 EYE PRURITUS 13 0.0004
733 TOOTHACHE 7 0.0004
734 EYE DISCHARGE 4 0.0004
735 SWELLING FACE 25 0.0004
736 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
737 ADVERSE REACTION 5 0.0004
738 BLOOD PRESSURE FLUCTUATION 9 0.0004
739 CARDIAC DISORDER 35 0.0004
740 THROMBOSIS 30 0.0004
741 HEREDITARY ANGIOEDEMA 4 0.0004
742 SKIN CANCER 8 0.0004
743 INTESTINAL OBSTRUCTION 14 0.0004
744 BLOOD SODIUM DECREASED 7 0.0004
745 HYPOGLYCAEMIA 18 0.0004
746 DISTURBANCE IN ATTENTION 20 0.0004
747 TINNITUS 17 0.0004
748 FRACTURE 7 0.0004
749 AMNESIA 24 0.0004
750 PULMONARY THROMBOSIS 4 0.0004
751 LETHARGY 21 0.0004
752 ANAEMIA 69 0.0004
753 FUNGAL INFECTION 12 0.0004
754 TRANSAMINASES INCREASED 8 0.0004
755 FEELING COLD 10 0.0004
756 HAEMORRHOIDS 7 0.0004
757 INJECTION SITE RASH 11 0.0004
758 SKIN FISSURES 7 0.0004
759 SOMNOLENCE 72 0.0004
760 CARPAL TUNNEL SYNDROME 5 0.0004
761 RASH PAPULAR 8 0.0004
762 MYOCARDIAL ISCHAEMIA 4 0.0004
763 DERMATITIS CONTACT 4 0.0004
764 ERECTILE DYSFUNCTION 9 0.0004
765 SUBDURAL HAEMATOMA 5 0.0003
766 IMPAIRED QUALITY OF LIFE 5 0.0003
767 RESPIRATORY TRACT INFECTION 9 0.0003
768 ORTHOSTATIC HYPOTENSION 6 0.0003
769 HYPOKINESIA 5 0.0003
770 ELECTROLYTE IMBALANCE 4 0.0003
771 SKIN EXFOLIATION 29 0.0003
772 INCORRECT DOSE ADMINISTERED BY DEVICE 9 0.0003
773 INJECTION SITE PRURITUS 23 0.0003
774 GASTROENTERITIS 5 0.0003
775 MEDICATION ERROR 19 0.0003
776 HYPERHIDROSIS 44 0.0003
777 COLD SWEAT 6 0.0003
778 ASCITES 10 0.0003
779 HYPOTENSION 68 0.0003
780 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
781 ARRHYTHMIA 16 0.0003
782 ATAXIA 4 0.0003
783 LOSS OF CONSCIOUSNESS 43 0.0003
784 RASH ERYTHEMATOUS 16 0.0003
785 THROAT TIGHTNESS 9 0.0003
786 TREMOR 55 0.0003
787 PELVIC PAIN 6 0.0003
788 PSORIASIS 43 0.0003
789 INCORRECT DOSE ADMINISTERED 75 0.0003
790 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 6 0.0003
791 SKIN DISCOLOURATION 15 0.0003
792 INJECTION SITE URTICARIA 8 0.0003
793 MUSCLE SPASTICITY 4 0.0003
794 DEPRESSION 74 0.0003
795 ECZEMA 17 0.0003
796 FLUSHING 33 0.0003
797 BONE PAIN 19 0.0003
798 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
799 GASTROINTESTINAL HAEMORRHAGE 27 0.0003
800 ANKLE FRACTURE 5 0.0003
801 TENDONITIS 5 0.0003
802 FEMUR FRACTURE 10 0.0003
803 HAEMOPTYSIS 9 0.0003
804 PHARYNGITIS 4 0.0003
805 EJECTION FRACTION DECREASED 5 0.0003
806 HAIR COLOUR CHANGES 4 0.0003
807 HAEMOGLOBIN DECREASED 33 0.0003
808 THERAPY PARTIAL RESPONDER 5 0.0003
809 OXYGEN SATURATION DECREASED 18 0.0003
810 DERMATITIS ALLERGIC 4 0.0003
811 COLITIS 12 0.0003
812 MUSCLE ATROPHY 4 0.0003
813 PULMONARY EMBOLISM 30 0.0003
814 CHILLS 37 0.0003
815 DISEASE RECURRENCE 15 0.0003
816 INJECTION SITE IRRITATION 4 0.0003
817 PRODUCTIVE COUGH 15 0.0003
818 EMOTIONAL DISTRESS 38 0.0003
819 BURNING SENSATION 22 0.0003
820 HEART RATE DECREASED 11 0.0003
821 HYPOXIA 11 0.0003
822 DEVICE ISSUE 28 0.0003
823 RHABDOMYOLYSIS 13 0.0003
824 SENSORY DISTURBANCE 5 0.0003
825 SYNCOPE 31 0.0003
826 DEEP VEIN THROMBOSIS 20 0.0003
827 NERVOUSNESS 16 0.0003
828 VISION BLURRED 42 0.0003
829 KIDNEY INFECTION 6 0.0003
830 CHOLELITHIASIS 10 0.0003
831 METASTASES TO BONE 5 0.0003
832 OSTEONECROSIS 10 0.0003
833 INCORRECT PRODUCT STORAGE 4 0.0003
834 BEDRIDDEN 4 0.0003
835 VENTRICULAR TACHYCARDIA 5 0.0003
836 DEPRESSED MOOD 16 0.0003
837 DYSMENORRHOEA 4 0.0003
838 SKIN DISORDER 10 0.0003
839 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
840 BLOOD BILIRUBIN INCREASED 8 0.0003
841 MOOD ALTERED 8 0.0003
842 INJECTION SITE WARMTH 6 0.0003
843 SWOLLEN TONGUE 9 0.0003
844 MENTAL STATUS CHANGES 8 0.0003
845 DEVICE DIFFICULT TO USE 19 0.0003
846 HAEMORRHAGE 30 0.0003
847 APHONIA 4 0.0003
848 IRRITABILITY 17 0.0003
849 HEAD DISCOMFORT 5 0.0003
850 DIALYSIS 4 0.0003
851 EATING DISORDER 6 0.0003
852 DEATH 242 0.0003
853 IMPAIRED WORK ABILITY 6 0.0003
854 INFLUENZA LIKE ILLNESS 23 0.0003
855 PARALYSIS 4 0.0003
856 HYPERSOMNIA 8 0.0003
857 HYPOACUSIS 12 0.0003
858 HALLUCINATION 21 0.0003
859 HYPERGLYCAEMIA 10 0.0003
860 HEPATITIS 7 0.0003
861 DYSURIA 10 0.0003
862 URINARY INCONTINENCE 8 0.0003
863 NEUTROPHIL COUNT DECREASED 11 0.0003
864 DIPLOPIA 7 0.0003
865 PULMONARY OEDEMA 12 0.0003
866 ORAL PAIN 6 0.0003
867 DYSPNOEA EXERTIONAL 10 0.0003
868 APHASIA 8 0.0003
869 INJECTION SITE PAIN 81 0.0003
870 PRODUCT SUBSTITUTION ISSUE 15 0.0003
871 NIGHTMARE 9 0.0003
872 TACHYCARDIA 23 0.0003
873 LYMPHOMA 4 0.0003
874 RASH MACULAR 9 0.0003
875 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
876 PLASMA CELL MYELOMA 10 0.0003
877 DEVICE MALFUNCTION 18 0.0003
878 DEVICE DELIVERY SYSTEM ISSUE 7 0.0003
879 LYMPHADENOPATHY 9 0.0003
880 DISORIENTATION 10 0.0003
881 PNEUMOTHORAX 4 0.0003
882 PREMATURE DELIVERY 4 0.0003
883 SPINAL FRACTURE 5 0.0002
884 FULL BLOOD COUNT DECREASED 5 0.0002
885 INJECTION SITE SWELLING 19 0.0002
886 EXTRA DOSE ADMINISTERED 10 0.0002
887 ENCEPHALOPATHY 6 0.0002
888 STAPHYLOCOCCAL INFECTION 8 0.0002
889 OSTEONECROSIS OF JAW 6 0.0002
890 INJECTION SITE ERYTHEMA 30 0.0002
891 TOOTH LOSS 5 0.0002
892 CYTOMEGALOVIRUS INFECTION 4 0.0002
893 NEEDLE ISSUE 7 0.0002
894 PULMONARY HYPERTENSION 5 0.0002
895 ERYTHEMA 49 0.0002
896 UNEVALUABLE EVENT 18 0.0002
897 ANGER 8 0.0002
898 UNRESPONSIVE TO STIMULI 6 0.0002
899 DRY SKIN 31 0.0002
900 VERTIGO 14 0.0002
901 METASTASES TO LIVER 4 0.0002
902 BRADYCARDIA 12 0.0002
903 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
904 DRUG ERUPTION 4 0.0002
905 TOOTH DISORDER 5 0.0002
906 NEOPLASM MALIGNANT 15 0.0002
907 CEREBRAL HAEMORRHAGE 8 0.0002
908 DYSKINESIA 9 0.0002
909 HEAD INJURY 7 0.0002
910 OSTEOMYELITIS 4 0.0002
911 INJECTION SITE REACTION 15 0.0002
912 LACTIC ACIDOSIS 7 0.0002
913 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
914 COGNITIVE DISORDER 10 0.0002
915 ACCIDENTAL EXPOSURE TO PRODUCT 22 0.0002
916 HYPOCALCAEMIA 4 0.0002
917 DEVICE LEAKAGE 9 0.0002
918 HAEMATOCRIT DECREASED 4 0.0002
919 DEVICE USE ERROR 7 0.0002
920 INJECTION SITE HAEMORRHAGE 16 0.0002
921 GASTRIC CANCER 5 0.0002
922 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
923 HYPONATRAEMIA 11 0.0002
924 SKIN ULCER 5 0.0002
925 HAEMATOMA 5 0.0002
926 EXPOSURE VIA SKIN CONTACT 5 0.0002
927 CARDIO-RESPIRATORY ARREST 8 0.0002
928 DEAFNESS 5 0.0002
929 MOUTH ULCERATION 4 0.0002
930 NO ADVERSE EVENT 34 0.0002
931 HIP FRACTURE 6 0.0002
932 FEAR 5 0.0002
933 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
934 PRODUCT PRESCRIBING ISSUE 4 0.0002
935 SKIN LESION 5 0.0002
936 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
937 MELAENA 4 0.0002
938 DRUG DOSE OMISSION 30 0.0002
939 RESPIRATORY ARREST 5 0.0002
940 ABNORMAL DREAMS 5 0.0002
941 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
942 PROCEDURAL PAIN 5 0.0002
943 PANCYTOPENIA 10 0.0002
944 DEMENTIA 5 0.0002
945 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
946 LIVER FUNCTION TEST ABNORMAL 5 0.0002
947 BREAST CANCER 16 0.0002
948 DERMATITIS ATOPIC 9 0.0002
949 PSYCHOTIC DISORDER 5 0.0002
950 PANIC ATTACK 6 0.0002
951 RESPIRATORY FAILURE 12 0.0002
952 LEUKOPENIA 8 0.0002
953 CARDIAC ARREST 13 0.0002
954 MOOD SWINGS 5 0.0002
955 SEIZURE 18 0.0002
956 ANAPHYLACTIC SHOCK 4 0.0002
957 SPEECH DISORDER 8 0.0002
958 GASTRITIS 4 0.0002
959 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
960 PROSTATE CANCER 12 0.0001
961 JAUNDICE 4 0.0001
962 PAIN OF SKIN 4 0.0001
963 NEUTROPENIA 20 0.0001
964 PANCREATIC CARCINOMA 4 0.0001
965 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
966 RESTLESSNESS 5 0.0001
967 BLADDER CANCER 8 0.0001
968 ACNE 10 0.0001
969 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
970 EMOTIONAL DISORDER 4 0.0001
971 DRUG DOSE OMISSION BY DEVICE 10 0.0001
972 ABNORMAL BEHAVIOUR 5 0.0001
973 RENAL CANCER 6 0.0001
974 MULTIPLE SCLEROSIS 6 0.0001
975 GASTRIC DISORDER 4 0.0001
976 NEOPLASM PROGRESSION 4 0.0001
977 INTENTIONAL OVERDOSE 7 0.0001
978 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
979 DYSARTHRIA 4 0.0001
980 COMA 5 0.0001
981 AGGRESSION 5 0.0001
982 DEVICE BREAKAGE 4 0.0001
983 LUNG NEOPLASM MALIGNANT 4 0.0001
984 ANGIOEDEMA 4 0.0001
985 THROMBOCYTOPENIA 10 0.0001
986 DISEASE PROGRESSION 10 0.0001
987 SUICIDAL IDEATION 7 0.0001
988 OVERDOSE 13 0.0001
989 DRUG WITHDRAWAL SYNDROME 5 0.0001
990 AGITATION 4 0.0001
991 TOXICITY TO VARIOUS AGENTS 5 0.0000